On April 22, our company obtained the "Certificate of Registration of Pharmaceutical Raw Materials" of the Dried Rhizoma Coptidis Extract issued by the Ministry of Food and Drug Safety of Korea (MFDS). The successful registration of this project paved the way for the subsequent registration of our plant extract products in Korea, and at the same time, it marked the new stage of the expansion of our plant extract products in the Korean pharmaceutical market.